Back
Agios Pharmaceuticals 10K Form
Sell
31
AGIO
Agios Pharmaceuticals
Last Price:
42.64
Seasonality Move:
-2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
| 2023-11-02 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
| 2023-08-03 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
| 2023-05-04 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
| 2022-08-04 | 10Q | AGIO/Agios Pharmaceuticals Quarterly |
Receive AGIO News And Ratings
See the #1 stock for the next 7 days that we like better than AGIO
AGIO Financial Statistics
Sales & Book Value
| Annual Sales: | $26.82M |
|---|---|
| Cash Flow: | $-100.01M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $13.11 |
| Price / Book: | 3.21 |
Profitability
| EPS (TTM): | -6.32000 |
|---|---|
| Net Income (TTM): | $-352.62M |
| Gross Margin: | $23.94M |
| Return on Equity: | -39.69% |
| Return on Assets: | -35.05% |
Agios Pharmaceuticals Earnings Forecast
Key Agios Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 11 years for AGIO is 89.26%.
- The Selling, General & Administrative Expenses for AGIO have been equal to 447.02% of Gross Profit Margin.
- The Research & Development expenses have been 1,101.76% of Revenue.
- The Interest Expense is -5.45% of Operating Income.
- The Net Earning history of AGIO is -1,312.63% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 4 years.
Agios Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AGIO |
| CUSIP: | 00847X |
| Website: | agios.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.84 |
| Quick Ratio: | 11.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AGIO Technical Analysis vs Fundamental Analysis
Sell
31
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy or a Sell?
-
Agios Pharmaceuticals stock is rated a Sell
The current Agios Pharmaceuticals [AGIO] share price is $42.02. The Score for AGIO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.